Cargando…
Relationship between the inclusion/exclusion criteria and sample size in randomized controlled trials for SARS-CoV-2 entry inhibitors
The coronavirus disease 2019 (COVID-19) pandemic that has been ongoing since 2019 is still ongoing and how to control it is one of the international issues to be addressed. Antiviral drugs that reduce the viral load in terms of reducing the risk of secondary infection are important. For the general...
Autores principales: | Tatematsu, Daiki, Akao, Marwa, Park, Hyeongki, Iwami, Shingo, Ejima, Keisuke, Iwanami, Shoya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Authors. Published by Elsevier Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794526/ https://www.ncbi.nlm.nih.gov/pubmed/36586664 http://dx.doi.org/10.1016/j.jtbi.2022.111403 |
Ejemplares similares
-
Incomplete antiviral treatment may induce longer durations of viral shedding during SARS-CoV-2 infection
por: Kim, Kwang Su, et al.
Publicado: (2021) -
Estimation of timing of infection from longitudinal SARS-CoV-2 viral load data: mathematical modelling study
por: Ejima, Keisuke, et al.
Publicado: (2022) -
Time variation in the probability of failing to detect a case of polymerase chain reaction testing for SARS-CoV-2 as estimated from a viral dynamics model
por: Ejima, Keisuke, et al.
Publicado: (2021) -
Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study
por: Iwanami, Shoya, et al.
Publicado: (2021) -
Estimation of the incubation period of COVID-19 using viral load data
por: Ejima, Keisuke, et al.
Publicado: (2021)